15-05-2024
|
|
|
Report of Monitoring Agency issued by ICRA Limited for the quarter ended March 31, 2024 |
|
|
|
06-05-2024
|
|
|
Entero Healthcare Solutions Limited has informed the Exchange about Acquisition of 80% paidup equity share capital of Avenir Lifecare Pharma Private Limited ( ALPPL ) |
|
|
|
06-05-2024
|
|
|
ENTERO HEALTHCARE SOLUTIONS LIMITED has informed the Exchange regarding Acquisition |
|
|
|
06-05-2024
|
|
|
Entero Healthcare Solutions Limited has informed the Exchange regarding Board meeting held on May 06, 2024. |
|
|
|
24-04-2024
|
|
|
Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet |
|
|
|
12-04-2024
|
|
|
Prabhat Agrawal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
|
|
10-04-2024
|
|
|
Certificate under Regulation 74(5) of Securities and Exchange Board of India(Depositories and Participants) Regulations, 2018 for the Quarter ended March 31, 2024. |
|
|
|
10-04-2024
|
|
|
OrbiMed Asia III Mauritius Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
|
|
05-04-2024
|
|
|
Disclosure in compliance with SEBI Circular No. SEBI/HO/CFD/CMDl/CIR/2019/140 dated November 21, 2019, of default on payment of interest/ repayment of principal amount on loans from Bank( s)/ financial institutions and unlisted debt securities |
|
|
|
28-03-2024
|
|
|
Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
|